Skip to content
Sign in

TDOC · NYSE

Teladoc Health (TDOC) Stock Price & Fundamentals

$754.18−0.39%−$2.92End-of-day price as of Oct 9, 2026

Teladoc Health (TDOC) closed at $754.18 on Oct 9, 2026, down 0.39% from the previous close of $757.10.

Share price, past year

1Y +37.59%

52-week range $545.52 – $757.10. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$754.18
Sep 30, 2026$706.05
Aug 31, 2026$692.47
Jul 31, 2026$667.61
Jun 30, 2026$632.39
May 29, 2026$587.63
Apr 30, 2026$593.71
Mar 31, 2026$583.15
Feb 27, 2026$553.16
Jan 30, 2026$561.38
Dec 31, 2025$573.36
Nov 28, 2025$631.90
Oct 31, 2025$613.50

Key statistics

Market cap
$137.00B
P/E (TTM)
—
EPS (TTM)
−$0.99
Revenue (TTM)
$2.49B
Net income (TTM)
−$177.40M
Shares outstanding
181.6M
Dividend yield
—
52-week range
$545.52 – $757.10

Teladoc Health's market cap is $137.00B, based on a share price of $754.18 and 181.6M shares outstanding as of Jun 30, 2026.

Financials

Teladoc Health reported revenue of $2.53B for fiscal 2025, down 1.54% from fiscal 2024.

Teladoc Health reported a net loss of $200.32M in fiscal 2025.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Teladoc Health annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$2.53B−1.5%−$200.32M−7.9%−$1.14$285.46M
FY2024ended Dec 31, 2024$2.57B−1.3%−$1.00B−39.0%−$5.87$282.89M
FY2023ended Dec 31, 2023$2.60B+8.1%−$220.37M−8.5%−$1.34$338.56M
FY2022ended Dec 31, 2022$2.41B+18.4%−$13.66B−567.5%−$84.60$172.81M
FY2021ended Dec 31, 2021$2.03B+85.8%−$428.79M−21.1%−$2.73$185.46M
FY2020ended Dec 31, 2020$1.09B+97.7%−$485.14M−44.4%−$5.36−$57.54M
FY2019ended Dec 31, 2019$553.31M+32.4%−$98.86M−17.9%−$1.38$26.36M
FY2018ended Dec 31, 2018$417.91M+79.1%−$97.08M−23.2%−$1.47−$8.87M
FY2017ended Dec 31, 2017$233.28M+89.4%−$106.78M−45.8%−$1.93−$37.07M
FY2016ended Dec 31, 2016$123.16M—−$74.22M−60.3%−$1.75−$53.98M
Teladoc Health quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$606.93M−$38.91M−$0.21
Q1 FY2026ended Mar 31, 2026$613.85M−$63.84M−$0.36
Q4 FY2025ended Dec 31, 2025$642.27M−$25.14M−$0.14
Q3 FY2025ended Sep 30, 2025$626.44M−$49.51M−$0.28
Q2 FY2025ended Jun 30, 2025$631.90M−$32.66M−$0.19
Q1 FY2025ended Mar 31, 2025$629.37M−$93.01M−$0.53
Q4 FY2024ended Dec 31, 2024$640.49M−$48.41M−$0.27
Q3 FY2024ended Sep 30, 2024$640.51M−$33.28M−$0.19

Company profile

Name
Teladoc Health, Inc.
Ticker
TDOC
Exchange
NYSE
Industry (SEC SIC)
Services-Offices & Clinics of Doctors of Medicine
Headquarters
155 E 44th Street, Suite 1700, New York, NY 10017
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001477449

Recent SEC filings

Frequently asked questions

What is Teladoc Health's stock price?

Teladoc Health (TDOC) closed at $754.18 on Oct 9, 2026, down 0.39% from the previous close of $757.10.

What is Teladoc Health's market cap?

Teladoc Health's market cap is $137.00B, based on a share price of $754.18 and 181.6M shares outstanding as of Jun 30, 2026.

How much revenue does Teladoc Health make?

Teladoc Health reported revenue of $2.53B for fiscal 2025, down 1.54% from fiscal 2024.

Does Teladoc Health pay a dividend?

Teladoc Health's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Teladoc Health, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures